Beechams Max Strength All in One Hot Cranberry and Blackcurrant oral powder sachets

Krajina: Spojené kráľovstvo

Jazyk: angličtina

Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktívna zložka:

Guaifenesin; Phenylephrine hydrochloride; Paracetamol

Dostupné z:

Haleon UK Ltd

ATC kód:

N02BE51

INN (Medzinárodný Name):

Guaifenesin; Phenylephrine hydrochloride; Paracetamol

Dávkovanie:

200mg ; 12.2mg ; 1gram

Forma lieku:

Powder for oral solution

Spôsob podávania:

Oral

Trieda:

No Controlled Drug Status

Typ predpisu:

Never Valid To Prescribe As A VMP

Prehľad produktov:

BNF: ; GTIN: 5000347045110

Príbalový leták

PHARMA CODE REF. NO. 1403
PHARMA CODE REF. NO. 1403
_HOT CRANBERRY & BLACKCURRANT_
_Powder For Oral Solution_
_PARACETAMOL, PHENYLEPHRINE, GUAIFENESIN_
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU TAKE THIS MEDICINE
BECAUSE IT
CONTAINS IMPORTANT INFORMATION YOU NEED TO KNOW. This medicine is
available
without prescription, however you still need to use this product
carefully to get
the best results from it.
•
Keep this leaflet as you may need to read it again.
•
Ask your pharmacist if you need more information or advice.
1. What is this medicine and what is it used for?
THIS MEDICINE CONTAINS:
•
PARACETAMOL which is a pain reliever (analgesic) and helps reduce your
temperature when you have a fever
•
GUAIFENESIN which is an expectorant to help loosen phlegm
•
PHENYLEPHRINE which is a decongestant to reduce swelling in the
passages of
the nose to help you breathe more easily
This medicine provides relief from the symptoms of colds and flu with
chesty
cough, including feverishness and chills, headache, sore throat pain,
aches and
pains, nasal congestion, sinusitis and its associated pain, and acute
nasal catarrh.
2.
Is this medicine suitable for you?
DO NOT TAKE THIS MEDICINE:
•
if you are ALLERGIC to paracetamol, guaifenesin, phenylephrine or any
of the
other ingredients (see section 6)
•
if you have KIDNEY or LIVER PROBLEMS (including alcoholic liver
disease),
OVERACTIVE THYROID, DIABETES, HIGH BLOOD PRESSURE or HEART DISEASE
•
if you have GLAUCOMA or PHAEOCHROMOCYTOMA
•
if you are taking
BETA BLOCKERS
(e.g. atenolol), TRICYCLIC ANTIDEPRESSANTS (e.g.
imipramine or amitriptyline) or if you are taking or have taken in the
last TWO
WEEKS MONOAMINE OXIDASE INHIBITORS (MAOIs) prescribed for DEPRESSION.
DO NOT TAKE ANYTHING ELSE CONTAINING PARACETAMOL WHILE TAKING THIS
MEDICINE.
DO NOT TAKE WITH ANY OTHER FLU, COLD, DECONGESTANT PRODUCTS OR COUGH
SUPPRESSANTS.
TAKE SPECIAL CARE WITH THIS MEDICINE
•
This medicine may cause dizziness. If affected do not drive or operate
machinery.
ASK YOUR DOCTOR BEF

Súhrn charakteristických

OBJECT 1
BEECHAMS MAX STRENGTH ALL IN ONE HOT
CRANBERRY AND BLACKCURRANT POWDER FOR ORAL
SOLUTION
Summary of Product Characteristics Updated 27-Jun-2016 |
GlaxoSmithKline Consumer Healthcare
1. Name of the medicinal product
Beechams Max Strength All in One Hot Cranberry and Blackcurrant,
powder for oral solution
2. Qualitative and quantitative composition
Each single-dose sachet contains paracetamol 1000 mg, guaifenesin 200
mg and phenylephrine
hydrochloride 12.2 mg.
Excipients:
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Powder for oral solution.
Grey to purple fine powder with a cranberry odour.
4. Clinical particulars
4.1 Therapeutic indications
This product is indicated in adults and children aged 16 years and
older for the short-term relief of the
symptoms of influenza, feverishness, chills and colds including
headache, chesty cough, sore throat pain,
aches and pains, nasal congestion, sinusitis and its associated pain,
and acute nasal catarrh.
4.2 Posology and method of administration
POSOLOGY
ADULTS (INCLUDING THE ELDERLY) AND CHILDREN AGED 16 YEARS AND OVER:
One sachet, dissolved in a standard mug of hot water but not boiling
water (approximately 250 ml), to be
taken every four to six hours, up to a maximum of four sachets in any
24 hours.
Minimum dosing interval: four hours
Do not exceed the stated dose.
Maximum duration of continued use without medical advice: 7 days.
PAEDIATRIC POPULATION
CHILDREN UNDER 16 YEARS OF AGE:
Not to be given to children under 16 years of age, except under
medical advice.
The safety of this product in children aged from birth to 16 years of
age has not been established (see
section 5.1). No data are available.
POPULATIONS
PATIENTS WITH HEPATIC IMPAIRMENT:
Patients who have been diagnosed with hepatic impairment must seek
medical advice before taking this
medicine. The restrictions related to the use of such combinations in
patients with hepatic impairment are
primarily a consequence of the paracetamol content of the product (see
Section 4.4 Special